St. Jude Medical, Inc. (NYSE:STJ)

CAPS Rating: 4 out of 5

Develops, manufactures and distributes cardiovascular medical devices for the cardiac rhythm management, cardiac surgery, cardiology, and atrial fibrillation therapy areas and implantable neuromodulation devices for the management of chronic pain.

Results 41 - 58 of 58 : « Previous 1 2 3

Recs

0
Member Avatar JUMPKIS (97.37) Submitted: 2/4/2007 3:16:19 PM : Underperform Start Price: $41.06 STJ Score: +0.85

1. Make profit

2. Target market: the heart issue sufferers, profitable

3. field saturated with competitors that see the exact same thing

As with anpi, on bad device could spoil the pot.

Recs

0
Member Avatar gEEkguy (< 20) Submitted: 2/2/2007 1:29:40 PM : Outperform Start Price: $40.83 STJ Score: -0.26

ICD market is under penetrated.

Recs

1
Member Avatar riverdude (89.83) Submitted: 1/30/2007 9:49:18 PM : Outperform Start Price: $41.24 STJ Score: -2.71

Strong company at a value, near 52 week low.

Recs

0
Member Avatar dy542340 (< 20) Submitted: 1/29/2007 12:51:25 PM : Outperform Start Price: $40.86 STJ Score: -1.88

ICD sales will return to double digit growth in 2007. SJM will be an acquisition target

Recs

0
Member Avatar gostj (60.18) Submitted: 12/7/2006 5:19:32 PM : Outperform Start Price: $37.57 STJ Score: +5.59

ICD market to rebound

Recs

0
Member Avatar mminacci (< 20) Submitted: 12/7/2006 5:11:19 PM : Underperform Start Price: $37.57 STJ Score: -5.59

ICD market that SJM relies heavily on is stagnet.

Recs

0
Member Avatar urig6 (< 20) Submitted: 11/24/2006 12:22:22 PM : Underperform Start Price: $36.52 STJ Score: -7.85

It will be aquired

Recs

0
Member Avatar buzzsaw52 (< 20) Submitted: 11/16/2006 5:35:25 PM : Outperform Start Price: $34.92 STJ Score: +12.73

New, physician friendloy software will give it an edge

Recs

0
Member Avatar marks37 (< 20) Submitted: 11/2/2006 5:43:25 PM : Outperform Start Price: $32.97 STJ Score: +17.46

selling is overdone

Recs

0
Member Avatar Phoebe1225 (< 20) Submitted: 10/23/2006 4:24:37 PM : Outperform Start Price: $33.45 STJ Score: +15.73

The premier leader in the sector, hands down.

Recs

0
Member Avatar 1jeshua (32.22) Submitted: 10/11/2006 2:44:30 AM : Outperform Start Price: $37.44 STJ Score: +1.32

After the Acquisition, and everything is finally back to normal.

Recs

0
Member Avatar furleather (74.81) Submitted: 10/4/2006 7:01:07 PM : Outperform Start Price: $36.36 STJ Score: +3.97

equity was oversold, now at an attractive entry point

Recs

1
Member Avatar hd4fun (69.65) Submitted: 10/4/2006 11:44:08 AM : Outperform Start Price: $36.16 STJ Score: +4.29

continuing to take market share

Recs

0
Member Avatar mezell777 (82.76) Submitted: 9/28/2006 10:14:17 PM : Outperform Start Price: $34.61 STJ Score: +9.10

This is a $60 stock trading at a 40% discount, IMO.

Recs

3
Member Avatar bebop111 (< 20) Submitted: 9/27/2006 6:22:21 PM : Outperform Start Price: $33.76 STJ Score: +12.00

Only 10% off its 52-week bottom, poised to break through resistance point. A growth stock, with a bit of value now, the PEG is a respectable 1.55. With great operating margin, and return on equity, and especially, new products expected down the line, this should get into the mid 40's in next 6 months.

Recs

0
Member Avatar johntdang (87.67) Submitted: 9/21/2006 8:28:46 PM : Outperform Start Price: $35.69 STJ Score: +3.86

Baby boomer play.

Recs

0
Member Avatar doktorv (64.26) Submitted: 9/5/2006 10:21:30 PM : Outperform Start Price: $35.47 STJ Score: +3.56

Forget ICD sales in the USA. Focus on worldwide growth.

Recs

0
Member Avatar philshang (< 20) Submitted: 8/30/2006 4:50:52 AM : Outperform Start Price: $36.02 STJ Score: +1.86

Great management, heavy R&D expenditures, good focus on customers

Results 41 - 58 of 58 : « Previous 1 2 3

Featured Broker Partners


Advertisement